Results 341 to 350 of about 12,578,124 (406)

Hepatic NMNAT1 is required to defend against alcohol-associated fatty liver disease. [PDF]

Sci Adv
Ding Q, Cao F, Zhuge H, Lai S, Cao W, Wei H, Guo R, Qiu J, Song Q, Pei L, Li C, Si C, Sun Z, Song Z, Dou X, Li S.   +15 more
europepmc   +1 more source

Understanding Contributors of Resilience in Youth With Childhood‐Onset Systemic Lupus Erythematosus Through a Socioecological Lens: A Mixed‐Methods Study

Arthritis Care &Research, EarlyView.
Objective This study aimed to identify themes contributing to resilience in childhood‐onset systemic lupus erythematosus (cSLE), distinguish between profiles of resilience, and examine how they relate to underlying themes and patient characteristics. Methods We conducted a mixed‐methods study of 21 patients with cSLE aged 11 to 19 years at a Canadian ...
Isabella Zaffino, Louise Boulard, Joanna Law, Asha Jeyanathan, Lawrence Ng, Sandra Williams‐Reid, Kiah Reid, Angela Cortes, Eugene Cortes, Ashley Danguecan, Deborah M. Levy, Linda T. Hiraki, Andrea M. Knight   +12 more
wiley   +1 more source

Impact of Socio-Economic, Behavioural and Clinical Factors on Liver Disease Progression in Individuals With HIV and Hepatitis B. [PDF]

Liver Int
Ramier C, Boyd A, Smit C, van Zoest R, Claassen MAA, Pogány K, Posthouwer D, de Vries-Sluijs TEMS, Carrieri P, Van der Valk M.   +9 more
europepmc   +1 more source

The Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]

Int J Mol Sci
Beyoğlu D, Idle JR.
europepmc   +1 more source

Immune responses and recovery from spotty liver disease in layer birds. [PDF]

Poult Sci
Eastwood S, Wilson TB, Huang J, Campbell BE, Scott PC, Moore RJ, Van TTH.   +6 more
europepmc   +1 more source

Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis. [PDF]

World J Cardiol
Bharaj IS, Brar AS, Kahlon J, Singh A, Hotwani P, Kumar V, Sohal A, Batta A.   +7 more
europepmc   +1 more source

Managing Nonalcoholic Fatty Liver Disease Through Structured Lifestyle Modification Interventions. [PDF]

Am J Lifestyle Med
Thomas A, Thomas A.
europepmc   +1 more source

Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults. [PDF]

NPJ Gut Liver
Oduwole O, Ding C, Bitar N, Nair D, Salter S, Silverman M, Allen R, Ng Fat L, Tsochatzis E, Bell S, Mehta G, Britton A.   +11 more
europepmc   +1 more source

Projected Trends in Metabolic Dysfunction-Associated Steatotic Liver Disease Mortality Through 2040.

JAMA Netw Open
Zhang X, Linden S, Levesley CR, He X, Yang Z, Barnet SD, Cheung R, Ji F, Nguyen MH.   +8 more
europepmc   +1 more source